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TLQP-21 (TLQPPASSRRRHFHHALPPAR) is a multifunctional peptide that is involved
in the control of physiological functions, including feeding, reproduction, stress
responsiveness, and general homeostasis. Despite the huge interest in TLQP-
21 biological activity, very little is known about its intracellular mechanisms of
action. In microglial cells, TLQP-21 stimulates increases of intracellular Ca2+
that may activate functions, including proliferation, migration, phagocytosis and
production of inflammatory molecules. Our aim was to investigate whether JMV5656
(RRRHFHHALPPAR), a novel short analogue of TLQP-21, stimulates intracellular Ca2+
in the N9 microglia cells, and whether this Ca2+ elevation is coupled with the activation
Ca2+-sensitive K+ channels. TLQP-21 and JMV5656 induced a sharp, dose-dependent
increment in intracellular calcium. In 77% of cells, JMV5656 also caused an increase in
the total outward currents, which was blunted by TEA (tetraethyl ammonium chloride),
a non-selective blocker of voltage-dependent and Ca2+-activated potassium (K+)
channels. Moreover, the effects of ion channel blockers charybdotoxin and iberiotoxin,
suggested that multiple calcium-activated K+ channel types drove the outward current
stimulated by JMV5656. Additionally, inhibition of JMV5656-stimulated outward currents
by NS6180 (4-[[3-(trifluoromethyl)phenyl]methyl]-2H-1,4 benzothiazin-3(4H)-one) and
TRAM-34 (triarylmethane-34), indicated that KCa3.1 channels are involved in this
JMV5656 mechanisms of action. In summary, we demonstrate that, in N9 microglia
cells, the interaction of JMV5656 with the TLQP-21 receptors induced an increase
in intracellular Ca2+, and, following extracellular Ca2+ entry, the opening of KCa3.1
channels.
Keywords: TLQP-21, microglia, patch clamp, Ca2+-activated K+ channels, K+ current
INTRODUCTION
Microglial cells play a pivotal role in the first line of host defense in the central nervous system
(Plata-Salaman, 1991). Activated microglia can secrete pro-inflammatory and pro-nociceptive
mediators including, but not limited to, tumor necrosis factor (TNF), interleukins 1β, 6, 10,
and 18 (IL-1β, IL-6, IL-10, and IL-18), and brain-derived growth factor (BDNF), all of which
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may be involved in the pathogenesis of chronic and neuropathic
pain (Opree and Kress, 2000; Coull et al., 2005; Berta et al.,
2014). Neuropathic pain, developing as the result of central or
peripheral nervous system damages, is an important clinical
problem. Comparison of gene expression profiles in primary
sensory neurons following various insults has shown that VGF
(non-acronymic) expression was always up-regulated (Maratou
et al., 2009). VGF mRNA is expressed throughout the central
and the peripheral nervous system. In the rat, the highest
levels of VGF mRNA have been measured in the arcuate
nucleus of the hypothalamus and in the granular layer of the
cerebellum (Snyder and Salton, 1998). VGF is a member of the
extended granin family (Bartolomucci et al., 2011), comprising
acidic ubiquitous proteins present in secretory cells of the
nervous, endocrine and immune systems. It is a propeptide
of 617 amino acids in length in mouse and rat, 615 amino
acids in human with a highly conserved sequence presenting
only variation of 1–2 amino acids in different species. It is
processed by PC1/3 and PC2 prohormone convertases to yield
several bioactive peptides (Levi et al., 2004). VGF and peptides
derived from its processing have been found in dense core
vesicles and are released from neuronal and neuroendocrine
cells via the regulated secretory pathway (Possenti et al., 1999).
TLQP-21 (VGF556−576) is one of most studied among VGF-
derived neuropeptides, it is a multifunctional protein which
modulates lipolysis, energy balance, gonadotropin, and insulin
release, as well as gastroenteric functions and inflammatory pain
(Bartolomucci et al., 2006; Severini et al., 2009; Pinilla et al.,
2011; Possenti et al., 2012). As far as concerned its action
on microglial cells, it has been reported that the activity of
C3AR1, a receptor of TLQP-21 that is expressed in microglia,
has been implicated in a spectrum of immunomodulatory
processes; moreover, TLQP-21 seems to induce p38 MAP kinase
phosphorylation and this activation is related to the release of
prostaglandins from microglia. Finally, TLQP-21 may lead to
production and secretion of some cytokines through gC1qR
(Chen et al., 2013; Fairbanks et al., 2014). Although these
biological activities have stimulated enormous investigational
interest, very little is known about the mechanism of TLQP-
21 action at the cellular level. TLQP-21 displays saturable
binding to adipocyte membranes and atomic force microscopy
demonstrated the expression of a single class of binding sites
by CHO cells (Possenti et al., 2012; Cassina et al., 2013).
It has been reported that, TLQP-21 induces an increase in
intracellular calcium [Ca2+]i levels in ovary, microglial and
pituitary cells (Cassina et al., 2013; Chen et al., 2013; Petrocchi
Passeri et al., 2013), probably by mobilizing thapsigargin-
sensitive stores. In microglial cells, the resident macrophages of
the brain, the organization of intracellular Ca2+ signals results
from tightly coordinated fluxes of Ca2+ through intracellular
and plasmalemmal membranes (Verkhratsky and Parpura, 2014).
This implies a very precise coupling of the mechanisms regulating
intracellular calcium homeostasis with external stimuli involving
the consequent opening of Ca2+-activated potassium (K+)
channels. These potassium channels play a central role in
several microglial functions, including activation, respiratory
burst, proliferation, migration, phagocytosis, and production of
inflammatory molecules (Ohana et al., 2009; D’Alessandro et al.,
2013). Calcium activated potassium channels are a heterogeneous
family and are subgrouped on the basis of conductance as
large- (BK or KCa1.1), small- (SK or KCa2.3) and intermediate-
(IK or KCa3.1) conductance KCa channels. In principle, they
provide a polarizing and potassium extrusion-influence which is
integral to regulation of intracellular calcium homeostasis. It has
been reported that microglial cells express all the three families
of these calcium dependent channels (Kaushal et al., 2007;
Schlichter et al., 2010). Interestingly, the elevation in intracellular
Ca2+ levels is not sufficient to activate KCa3.1 and KCa2.3 in
microglia MLS-9 cells, whereas riluzole, a neuroprotective drug,
can activate both channels without inducing significant Ca2+
elevations (Ferreira and Schlichter, 2013).
The purpose of this study was to investigate whether JMV5656
(TLQP-219−21), a novel short analog of TLQP-21, can stimulate
an increase in intracellular Ca2+ in the murine microglial cell
line N9, and whether this Ca2+ elevation is coupled with the
activation of Ca2+-dependent K+ channels.
MATERIALS AND METHODS
Chemicals
TLQP-21 (TLQPPASSRRRHFHHALPPAR) and JMV5656
(RRRHFHHALPPAR) were synthesized by conventional solid
phase peptide synthesis and then purified on a C18 reversed phase
column. Each peptide was purified to a purity of at least 95% by
high-performance liquid chromatography (chromatograms are
shown in Supplementary Figure S1). Unless specified, all other
reagents were from Sigma–Aldrich (St Louis, MO, USA).
Cell Cultures
The murine microglial N9 cells (Corradin et al., 1993) were
grown in Iscove’s Modified Dulbecco’s Medium (IMDM; Sigma)
supplemented with 5% heat-inactivated fetal bovine serum (FBS),
2 mM L-glutamine, 100 IU/ml penicillin, 100µg/ml streptomycin
(Euroclone, Pero, Italy) and cultured in a controlled environment
(at 37◦C in humidified incubator with 5% CO2). Stock cells were
passaged 2–3 times/week with 1:10 split ratio and used within
eight passages.
Intracellular Ca2+ (Mobilization Assay)
N9 cells were plated at 20,000 cells/well into black walled, clear
bottom 96-well plate (Greiner Bio One, Kremsmünster, Austria)
and cultured two days up to 90-100% of confluence. Prior to
assay, cells were incubated in darkness with 100 µl of HBSS
solution containing 20 mM HEPES, 2.5 mM probenecid and
4.5 µM FLUO-4 NW (Molecular Probes, Eugene, OR, USA)
at 37◦C and 5% CO2 for 40 min. Probenecid is commonly
used to inhibit organic-anion transporters located in the cell
membrane to minimize the leakage of the intracellular dye back
to the extracellular environment. Fluorescence emissions were
measured with the multi-label spectrophotometer VICTOR3
(Perkin Elmer, MA, USA) at 485/535 nm (excitation/emission
filters) every 0.5 s for the 20 s preceding and for the 60 s
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following peptide exposure. TLQP-21 and JMV5656 (1 nM–
10 µM) were dissolved in HBSS and injected into the wells
by an automated injector system. Fluorescence data have been
calculated as (maximum fluorescence–basal fluorescence)/basal
fluorescence (1F/F), or the percent increase from the last value
before stimulation ((Fs/F0)∗100) where F0 is the last basal value
before stimulation and Fs is the stimulated value. To assure
reproducibility, each experiment has been repeated three times
in different days. To control for cell viability and compare
the magnitude of the stimulation achieved by TLQP-21 and
JMV5656, cells were also stimulated with 10 µM ATP dissolved
in HBSS.
Electrophysiological Recordings
For electrophysiological recordings, N9 cells were plated in p35
dishes (BD Falcon, Sacco, Milano, Italy) 24 h before patch-clamp
experiments and cultured in a controlled environment. Just
before the current measurements, culture medium was replaced
with an extracellular solution previously reported containing
135 mM NaCl, 5.4 mM KCl, 1.8 mM CaCl2, 1 mM MgCl2,
0.4 mM NaH2PO4, 10 mM HEPES, 10 mM glucose (Vecchietti
et al., 2006). Whole-cell patch-clamp recordings were performed
at room temperature (RT) using pipette pulled to a resistance
of 2–5 M (Model P-97 Sutter Instruments, Novato, CA,
USA). If not otherwise stated, the pipette intracellular solution
contained 122 mM KAsp, 20 mM KCl, 1 mM MgCl2, 1.6 mM
CaCl2, 10 mM HEPES, 5 mM EGTA. In this condition the free
intracellular Ca2+ concentration was 103,2 nM1. In experiments
that required intracellular free calcium concentration of 3 µM,
EGTA was lowered to 1.8 and CaCl2 increased to 1.7 mM.
In some experiments, EGTA was replaced with 5 mM BAPTA
as alternative calcium chelator. In each of these circumstances
the osmolarity was adjusted accordingly. Recordings were made
with a Multiclamp 700B amplifier, and data were digitized with
a Digidata 1440A and pClamp 10.3 software (all from Axon
Instruments, Molecular Devices, Sunnyvale, CA, USA). Results
were analyzed with Clampfit 10.3 software.
Before studying the effects of JMV5656 on ionic currents
in N9 cells, we tested whether the shear stress caused by the
superfusion itself could evoke an electrical activity of stretch-
activated channels. When stimulated with a step protocol of
400 ms duration, ranging from –120 to +60 mV every 5 s
for up to 5 min, from a holding potential of –80 mV, N9
cells did not exhibit differences in the total transmembrane
currents upon the superfusion with the extracellular solution
(n = 8; data not shown). These experiments confirmed that no
stretch-activated channels were activated under these conditions.
Therefore, superfused N9 cells could be considered as a suitable
model to study the electrophysiological effects of the peptide.
JMV5656 and channel blockers tetraethyl ammonium
chloride (TEA), 4-aminopyridine (4-AP), apamin, charybdotoxin
(CTX), iberiotoxin (IbTX), triarylmethane-34 (TRAM-34),
NS6180 were added to the bath solution. Extracellular solution
without calcium contained 135 mM NaCl, 5.4 mM KCl, 1.8 mM
1http://maxchelator.stanford.edu/CaEGTA-TS.htm
EGTA, 1 mM MgCl2, 0.4 mM NaH2PO4, 10 mM HEPES, 10 mM
glucose.
Every condition was tested as follow: the extracellular solution
containing any given channel blocker was superfused for a
minimum of 15 s. After the membrane currents had reached a
new equilibrium due to the effect of the perfusion (defined as
basal current), we applied the extracellular solution containing
the selected channel blocker and 10 µM JMV5656.
Silencing of KCa3.1 with siRNA
For mRNA silencing we used specific KCa3.1 siRNA duplex
(sense: 5′-CGGAGAAACACGUGCACAAdTdT-3′; antisense: 5′-
UUGUGCACGUGUUUCUCCGdTdT-3′) (Eurofins Genomics;
Vimodrone, Italy). To control for transfection non-specific effects
the negative control group was transfected with C3AR1 siRNA
(sense: 5′-GUGUACCAGUAUUUGUAUAdTdT-3′; antisense: 5′-
UAUACAAAUACUGGUACACdTdT-3′) (Eurofins Genomics).
Transfection was performed in a 24-well plate (Euroclone)
using DharmaFECT 1 Transfection Reagent (Thermo Scientific,
Lafayette, CO, USA) according to the manufacturer’s protocol.
Subsequent experiments were performed 24 h after transfection.
PCR
Total RNA was extracted from N9 cells using EuroGOLD Trifast
reagent (Euroclone). For each sample 160 ng of total RNA
were transcribed to cDNA using M-MLV Reverse Transcriptase
(Invitrogen, Waltham, MA, USA). cDNA was amplified by
PCR using GoTaq R© G2 DNA Polymerase (Promega, Madison,
WI, USA) and the following primers (Sigma): mouse KCa3.1
forward: 5′-CTGAGAGGCAGGCTGTCAATG-3′; mouse
KCa3.1 reverse: 5′-ACGTGTTTCTCCGCCTTGTT-3′; GAPDH
forward: 5′-GCCATCAACGACCCCTTCATTG-3′; GAPDH
reverse: 5′-TCTGTCATGAGGTTGGCTTTCAG-3′.
Statistical Analysis
Values are expressed as mean ± SE. The statistical significance
of differences between groups was evaluated with two-tailed
Student’s t-test or, when appropriate, by one-way analysis of
variance (ANOVA) followed by or Kruskal-Wallis test. A p-
value of less than 0.05 was considered statistically significant and
indicated with ∗ in the figures.
RESULTS
JMV5656 Stimulates Intracellular
Calcium Mobilization in N9 Cells
We have performed dose-response studies (1 nM–10 µM) to test
the activity of TLQP-21 and JMV5656 on N9 cells. Both peptides
induced a dose-dependent acute increase in intracellular calcium
(Figure 1A). The concentrations in the 0.1–10 µM range evoked
a significant increase in intracellular calcium levels in N9 cells,
reaching a plateau at the higher doses. Interestingly, JMV5656
was slightly more potent in inducing a calcium response than
TLQP-21 (EC50 TLQP-21: 0.96 µM vs. EC50 JMV5656: 0.45 µM).
The kinetic of calcium increase after stimulation showed that the
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FIGURE 1 | Effect of TLQP-21 and JMV5656 on calcium mobilization in N9 cells. (A) Dose-response study of intracellular calcium stimulation by TLQP-21 and
JMV5656. Intracellular calcium concentrations were measured in N9 cells using the fluorophore Fluo-4 NW as indicated in the Section “Materials and Methods”.
Data represent the peak values of intracellular calcium levels achieved for each concentration of the stimuli, and were calculated as 1F/F, meaning (maximum
fluorescence–basal fluorescence)/basal fluorescence. The 0 concentration is the 1F/F measured in cells stimulated with the vehicle only; the small increase in
fluorescence is likely induced by the injection procedure itself. Each point is the mean ± SE of 18 measurements obtained in three independent experiments. (B) A
representative time-course of intracellular calcium stimulation by JMV5656. Data were calculated as Fluorescence %, meaning (fluorescence after stimulation/last
basal fluorescence before stimulation)∗100. The effects of 10 µM ATP is shown for comparison. Arrows indicate injection of the stimuli. Fluorescence emissions were
measured at 485/535 nm (excitation/emission filters) every 0.5 s for the 20 s preceding and for the 60 s following peptide as indicated in the Section “Materials and
Methods”.
peak levels of intracellular calcium increase were reached in 3–4 s,
and basal levels restored within 20 s from stimulation (Figure 1B
and Supplementary Figure S2). Interestingly, 10 µM JMV5656
stimulated intracellular calcium rise with a kinetic comparable
to that of ATP 10 µM, but JMV5656 appeared more effective
(Figure 1B): about 37% increase in presence of JMV5656 and
20% in presence of ATP. Since it has been demonstrated that the
C-terminal region of TLQP-21 is the sequence retaining the full
biological activity (Cero et al., 2014) and likely also the region
primarily involved in the binding and activation of its receptor/s,
we decided to use 10 µM JMV5656 for the following patch-clamp
experiments.
JMV5656 Effects on N9 Cells
Transmembrane Currents
The perfusion of 10 µM JMV5656 induced an increase of
about threefold in the total outward currents in 79% of cells
tested (41 cells out of 52). The total outward currents increased
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FIGURE 2 | Effects of JMV5656 superfusion on N9 cells. (A,B) Representative families of currents traces acquired from N9 cells through a step protocol
from –120 to +60 mV applied form a holding potential of −80 mV in control conditions (A), and every five seconds from the opening of the perfusion with JMV5656
up to 40 s (B). (C) Current/voltage relationship in the presence of JMV5656. In the plot, the currents amplitude is presented as normalized relative to the baseline
current for each cell. Normalized currents measured were 0.92 ± 0.09 and 3.6 ± 0.5 after 40 s perfusion with extracellular solution and 10 µM JMV5656 (n = 25),
respectively. Data are presented as mean ± SE. (D) Bars graph showing the dose-response effect of the perfusion of JMV5656 measured at +60 mV (n = 8, 8 and
25 for 0.1 µM, 1 µM, and 10 µM, respectively. ∗p < 0.05 vs. 0.1 µM JMV5656).
to 33.3 ± 7.8 pA/pF, from a value of 10.9 ± 2.7 pA/pF
measured at baseline condition at 60 mV (Figures 2A–C).
Moreover, the value of the reversal potential hyperpolarized
from −19.6 ± 3.3 mV to –35.7 ± 8.3 mV (p < 0.05) after
40 s of the peptide perfusion (Figure 2C), time in which the
increase of the outward currents reached a plateau, before
returning to baseline (Supplementary Figure S3). This effect was
concentration-dependent (Figure 2D).
JMV5656 Activated Potassium Currents
in N9 Cells
The results obtained, in particular the hyperpolarization of the
reversal potential, suggested that the peptide could activate
a potassium current. Consequently, TEA, a non-selective
blocker of voltage-dependent and Ca2+-activated potassium
(K+) channels, was added to the extracellular solution at
10 mM in order to determine whether JMV5656 could influence
K+ currents. First, we recorded current traces in N9 cells
perfused with the extracellular solution containing 10 mM TEA
alone (Figure 3A). When TEA was subsequently administered
in combination with 10 µM JMV5656, the outer membrane
currents increased by 2.00 ± 0.3-fold (from 14.3 + 6.4
pA/pF in TEA alone to 26.5 ± 8.8 pA/pF in TEA+JMV5656,
values measured at 60 mV; p < 0.05) (Figures 3B,C). The
ability of TEA to attenuate JMV5656-stimulated outward
currents so significantly suggested an involvement of K+
channels activation in the N9 cells response to JMV5656
stimulation. In order to discriminate whether voltage-gated
K+ channels were involved in the response, we perfused
the cells with 5 mM 4-AP, a broad-spectrum blocker of
voltage-gated K+ channel (Figure 3D). Interestingly, 4-AP did
not inhibit the effect of JMV5656, which was still capable
to induce a 3.0 ± 1.1-fold increase of outward currents
(Figures 3E,F).
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FIGURE 3 | Effects of TEA and 4-AP on the superfusion of JMV5656 in N9 cells. (A,B) Representative families of current traces recorded in N9 cells perfused
with extracellular solution containing TEA (A) and after 40 s of perfusion with TEA plus JMV5656 peptide (B). (C) Current/voltage relationship at different time points
from the opening of the perfusion of extracellular solution containing TEA plus JMV5656. Currents are normalized to the value of the baseline current recorded at
+60 mV. Empty symbols indicates the presence of TEA, filled symbols the presence of TEA and JMV5656. (D,E) Representative families of current traces recorded
in N9 cells perfused with extracellular solution containing 4-AP (D) and after 40 s of perfusion with 4-AP plus JMV5656 peptide (E). (F) Current/voltage relationship
at different time points from the opening of the perfusion of extracellular solution containing 4-AP plus JMV5656. Currents are normalized to the value of the baseline
current recorded at +60 mV. Empty symbols indicate the presence of 4-AP, filled symbols the presence of 4-AP and JMV5656. Data are expressed as mean ± SE.
∗p < 0.05 vs respective baseline values (n = 5 in all conditions).
JMV5656 Activates Calcium-Dependent
Potassium Channels
Since JMV5656 dose-dependently boosted a significant increase
of intracellular calcium levels in N9 cells (Figure 1), we focused
our attention on the possible involvement of calcium-activated
potassium channels in its mechanism of action. To ascertain
whether KCa2 channels were engaged in this JMV5656 activity,
N9 cells were perfused with apamin, a drug that blocks KCa2.2
at 200 pM and KCa2.1 and KCa2.3 at nM concentrations (Wulff
et al., 2007). Interestingly, 100 nM apamin could not prevent the
rise of total outward currents stimulated by JMV5656 perfusion:
when measured at +60 mV, the current amplitude increased
about 2.5 ± 0.5-fold (p < 0.05) from 18.9 ± 6.7 pA/pF in
the apamin group to 45.8 ± 10 pA/pF in the apamin +
JMV5656 (Figure 4). These data suggested that KCa2 channels
were not primarily involved in JMV5656 mechanism of action.
Application of charybdotoxin (CTX, 100 nM), a KCa1.1, KCa3.1,
and voltage-gated Kv1.3 channel’s blocker (Gao and Garcia,
2003), instead, yielded a 1.25 ± 0.13-fold higher variation in
the outer currents compared to controls (Figure 4), suggesting
that KCa1.1 or KCa3.1 channels could be associated to the
JMV5656 mechanism of action. We ruled out the involvement
of Kv1.3 channels since they are also inhibited by TEA and
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FIGURE 4 | Effect of the perfusion of extracellular solutions containing
JMV5656 plus potassium channels blockers. Data are expressed as
current amplitude recorded at +60 mV after 40 s of perfusion and normalized
to the value of the baseline current recorded at the same voltage membrane.
Data are expressed as mean ± SE (n = at least eight cells for each condition)
∗p < 0.05 vs. JMV5656
4-AP (Comes et al., 2013). It is worthy to remember that KCa3.1
channels are insensitive to TEA, which instead, blocks KCa1.1
(Tricarico et al., 2013). When N9 cells were perfused with an
extracellular solution containing 100 nM iberiotoxin (IbTX) that
selectively inhibits KCa1.1 channels (Gao and Garcia, 2003),
JMV5656 was still capable of stimulating a partial increase of the
total outward currents (2.2 ± 0.5-fold), suggesting that KCa1.1
channels could be involved in the JMV5656 activated pathway
(Figure 4).
Thus, these results suggested that (i) JMV5656-stimulated
potassium outward current is not driven by a single type of
calcium activated K+ channel, and (ii) that both KCa1.1 and
KCa3.1 might be recruited.
JMV5656 Could Be Responsible for
KCa3.1 Channels Activation
NS6180, which has been recently identified as a novel KCa3.1
channel’s inhibitor (Strøbæk et al., 2013), was used to investigate
the potential involvement of KCa3.1 channels in the effects of
JMV5656 perfusion. When NS6180 at a concentration of 250 nM
was added to the superfusion solution containing the peptide, the
outward current declined of the 94,6 ± 4.6 % (n = 6, data not
shown), while no effect of the drug was visible on the baseline
currents (Supplementary Figure S4).
To further characterize the involvement of KCa3.1 channels in
the JMV5656 action, we measured the effects of TRAM-34, one of
the most recognized selective blocker of KCa3.1 channels (Wulff
et al., 2000). In this instance, N9 cells were (i) first superfused
either with the extracellular solution alone (Figure 5A) or with
the extracellular solution containing 10 µM JMV5656 for 25 s
(Figure 5B), an interval of time sufficient for JMV5656 effects to
become significant (the outer current increased from 15.0 ± 4.2
pA/pF to 37.5 ± 10.1 pA/pF; p < 0.05), and (ii) thereafter
switched to a solution containing JMV5656 and 2 µM TRAM-
34 (Figure 5C). The current amplitude decreased significantly
(19.0± 8.6 pA/pF) (Figures 5D,E).
Extracellular calcium is crucial for the activation of KCa3.1
channels (Ferreira and Schlichter, 2013) and indeed our data
indicate that JMV5656 failed to activate the outward currents
when the extracellular environment was devoid of Ca2+
(Figures 6A–D). In fact, the outward currents density measured
at +60 mV was similar before (11.2 ± 4.5 pA/pF) and after
JMV5656 superfusion (14.4 ± 7.1 pA/pF). Accordingly, when
extracellular calcium is chelated by the presence of EGTA 1 mM,
also the mobilization of the intracellular calcium is very low and
did not significantly differed from the control condition, blunting
the effect of JMV5656 (Figure 6E).
To further confirm a substantial involvement of KCa3.1 beside
KCa1.1 in the peptide response, we reasoned on the potassium
channel calcium sensitivity. Outward currents were recorded in
presence of 3 µM free intracellular calcium concentration, a
condition at which KCa3.1 is fully activated, while KCa1.1 is not.
In this scenario, we observed that the effect of JMV5656 was gone,
despite the reversal potential of the total transmembrane currents
was shifted in the hyperpolarized direction as it appeared after
the activation of the outward current by the peptide (Figure 6F).
Finally, in presence of BAPTA as intracellular calcium chelator,
JMV5656 failed to activate KCa currents (Figure 6G).
Inhibition of KCa3.1 Channels mRNA
Levels in N9 Cells
To confirm the role of KCa3.1 channels in JMV5656 effects, we
used specific siRNA to reduce the mRNA levels of this channel
in N9 cells. Transfection of KCa3.1 siRNA duplex significantly
reduced (p < 0.05) KCa3.1 mRNA levels (Figure 7A). Moreover,
after silencing KCa3.1 channels, there was a significant decrease in
the number of cells responsive to JMV5656 stimulation in terms
of activation of outward currents (Figure 7B). Cells responding
to JMV5656 decreased from 79% in control group to 33% in the
siRNA group. Among the responsive cells, the outward current
increase was confirmed to be of about 3.2 ± 0.7-fold. These
results support the hypothesis of a KCa3.1 involvement in the
JMV5656-induced effect.
DISCUSSION
The diversity of known biological- and medically relevant
activities for TLQP-21(VGF556−576) is expanding rapidly.
Accordingly, this study investigates modulation of selected
transmembranal ionic currents as an element of TLQP-21
intracellular signaling in the microglial cell model. TLQP-21
was initially immunopurified from rat brain and further
immunolocalized in gastric tissue as well as in adrenergic
neurons (Hahm et al., 1999; Bartolomucci et al., 2006; Brancia
et al., 2010). The known biological effects of TLQP-21 are diverse.
Although VGF knockout mice are smaller and thinner compared
Frontiers in Cellular Neuroscience | www.frontiersin.org 7 February 2017 | Volume 11 | Article 41
fncel-11-00041 February 21, 2017 Time: 14:55 # 8
Rivolta et al. JMV5656 Activates KCa Currents
FIGURE 5 | Effects of TRAM-34 on N9 cells superfused with JMV5656. (A–C) Representative families of current traces recorded in N9 cells before (A) and after
25 s (B) of perfusion with JMV5656 peptide and after 40 s of perfusion with JMV5656 peptide plus TRAM-34 (C). (D) Current/voltage relationship of baseline (empty
symbols), 25 s of JMV5656 perfusion (filled circles) and 40 s of TRAM-34 plus JMV5656 perfusion (filled triangles). Currents are normalized on the value of baseline
current recorded at +60 mV (n = 19). (E) Bar graph representing normalized current after 40 s of perfusion. Data have been obtained in three independent
experiments. Data are expressed as mean ± SE.
to their wild type littermates (Salton et al., 2000), TLPQ-21
was shown to induce anorexic effects, to activate lipolysis and
modulate inflammatory pain, and to blunt obesity induced by
diet (Bartolomucci et al., 2006, 2009; Rizzi et al., 2008). The
biological effects of TLQP-21 are receiving increasing attention,
but the specific receptor(s), which mediate its effects are still a
matter of considerable debate (Chen et al., 2013; Hannedouche
et al., 2013); moreover, there is little information about the
TLQP-21 mechanism of action. Our results demonstrate
that TLQP-21 like JMV5656 (i.e., TLQP-219−21) increased
intracellular calcium levels in N9 microglia cells. We have
decided to perform our experiments using the N9 immortalized
mouse microglia cells, which were previously demonstrated
to be a suitable model for studies on microglia (Bureau et al.,
2008; Wang et al., 2008) and might be a valuable alternative to
primary mouse microglia culture for use in pharmacological
and toxicological investigations. Microglial cells are known
to be the immune effector cells in the brain (Streit, 2004)
and the first line of defense against pathogens and acute or
chronic brain injuries. Reportedly, neurodegenerative diseases,
stroke and tumor invasion, induce an activation of microglia
cells that enclose damaged and dead cells and remove cellular
debris from the area, functioning as phagocytic macrophages.
Microglial cells are responsible for the release of a variety of
pro-inflammatory mediators such as cytokines, reactive oxygen
species, complement factors, neurotoxic secretory products, free
radical species, and nitric oxide (NO) which could contribute
to both neuronal dysfunction and cell death (Griffin et al.,
1998).
In N9 microglia cells, we have found that JMV5656 possesses
the same biological activity with slightly higher potency than
TLQP-21 in its ability to enhance [Ca2+]i. These results are in
agreement with the study of Cero et al. (Cero et al., 2014) who
demonstrated that the hot spots for the biological activity of
the TLQP-21 are in its C-terminus and that the retention of
its last thirteen amino acids is sufficient to have a peptide with
a comparable biological activity. In terms of quantification and
how high JMV5656 raised intracellular Ca2+, we could speculate
from what is known from the literature. In N13, a cell line
immortalized from primary mice microglial cell and very similar
to N9, the basal intracellular calcium concentration was found
to be about 150–200 nM (Ferrari et al., 1996). Since when we
stimulated with 10 µM JMV5656 the increase in calcium level
was of about 40%, we expect that the free calcium concentration
in this condition might be about 210–280 nM.
In microglia, the elevation of cytosolic calcium levels is
necessary for cytokine induction (Hoffmann et al., 2003) and
cellular activation. Moreover, previous studies reported a tight
association between intracellular calcium-dependent signaling
and Ca2+-dependent potassium channels activity (Stocker,
2004). For example, Ca2+-dependent potassium channels, such
as KCa1.1, KCa3.1, and KCa2.3 seemed to be linked in particular
to microglial activation processes (Bordey and Spencer, 2003;
Schlichter et al., 2010).
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FIGURE 6 | Extracellular and intracellular Ca2+ dependence of JMV5656 effect on KCa3.1 channels. (A,B) Representative families of currents traces
recorded in N9 cells perfused with the regular extracellular solution (A) and after 40 s of extracellular solution containing 0 mM Ca2+ and JMV5656 (B) in a condition
of intracellular free calcium concentration of 100 nM. (C) Current/voltage relationship during perfusion with the extracellular solution (baseline, empty symbols) and
perfusion containing JMV5656 (filled symbols) but lacking of Ca2+. (D) Normalized current amplitude recorded at +60 mV after 40 s of perfusion with extracellular
solution (n = 11), JMV5656 (n = 9), JMV5656 without extracellular Ca2+ (n = 15). (E) Cytosolic calcium mobilization, expressed as variation in fluorescence intensity,
obtained in N9 cells stimulated with the vehicle only (HBSS), with JMV5656 and with JMV5656 in presence of 1 mM EGTA to chelate the extracellular calcium. (F)
Current/voltage relationship obtained in presence of JMV5656 in the extracellular solution and BAPTA 5 mM in the intracellular one (n = 5). (G) Current/voltage
relationship obtained in presence of JMV5656 in the extracellular solution and 3 µM free intracellular calcium (n = 16); recording were made at selected time points
(5, 15, 25, and 40 s). ∗p < 0.05 vs control group. All data have been obtained in three independent experiments.
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FIGURE 7 | Effect of KCa3.1 siRNA on N9 cells superfused with
JMV5656. (A) Bars graph showing that KCa3.1 mRNA levels were
significantly reduced after transfection with 50 nM siRNA for 24 h. The inset
shows representative PCR: lane 1 N9; lane 2 N9 transfected with siRNA
negative control; lane 3–4 N9 transfected with KCa3.1 siRNA. (B) Bar graph
showing that in presence KCa3.1 siRNA the percentage of N9 cells responsive
to JMV5656 was reduced from 79% (control cells) to 33% (siRNA transfected
cells) (n = 9). Data are the mean ± SE of results obtained in three
independent experiments. ∗p < 0.05 vs control group.
Indeed, our data show that JMV5656 was responsible for the
activation of an outward K+ current which is calcium dependent
as revealed by charybdotoxin and iberiotoxin sensitivity. We
speculate that the general role of these potassium channels is
to provide a membrane polarizing influence (viz. potassium
eﬄux) which offsets the depolarizing action of calcium elevation,
and indirectly to maintain the driving force for optimal
calcium increase in the cytosol. Moreover, the calcium-activated
potassium channels help to regulate the volume of microglial cells
during migration. The changes of shape and volume seem to be
a prerequisite for cell migration. It is possible that in microglia,
calcium-activated potassium currents cause wrinkling of the cell
body, as proposed by Schwab (2001). This change of shape can
promote the migration, facilitating the retraction of the rear part
of the cell.
Interestingly, our results suggest that JMV5656 mainly, even
not specifically, activates KCa3.1 currents. In fact, while apamin, a
blocker of KCa2 when used in the nanomolar range, was not able
to prevent the increase in outward K+ currents, charybdotoxin
that inhibits KCa1.1, KCa3.1 channels (Gao and Garcia, 2003) and
iberiotoxin, that inhibits KCa1.1 (Salton et al., 2000), were capable
of blunting (the former in a complete way, the second partially)
the ability of JMV5656 to activate outward K+ currents. Further
details were gained by the use of NS6180 and TRAM-34, which
allowed proving that mostly the intermediate-conductance Ca2+-
activated K+ channels KCa3.1 were involved in the effects of
JMV5656 perfusion. Moreover, KCa3.1 activation depends on the
presence of extracellular calcium and this channel activity is not
induced by several stimuli that release Ca2+ from intracellular
stores but which do not stimulate Ca2+ influx (Cruse et al.,
2006), and our results are in line with this knowledge. To
strengthen the hypothesis of a prevalent contribution of KCa3.1
channels than KCa1.1 in the peptide response, we reasoned
on their respective calcium sensitivity. The typical intracellular
solution for whole cell measurements allowed us to have an free
calcium concentration of 100 nM, that is below the threshold
of the calcium-dependent activation of both KCa3.1 and KCa1.1.
The former channel relies on the use of calmodulin as Ca2+
sensor, thus shows an intrinsically high affinity for calcium,
while for the second, the calcium bowl requires higher calcium
concentration to activate the protein. Considering that JMV5656
induced a 40% increase of free [Ca2+]i (Figure 1B), the
intracellular calcium level reached after the peptide perfusion
was compatible with the activation of KCa3.1 (Joiner et al., 1997;
Ferreira and Schlichter, 2013) but not of the KCa1.1 (Rothberga
and Magleby, 2000). Furthermore, a [Ca2+]i of 3 µM, fully
activates KCa3.1, while the full activation of KCa1.1 required
10 µM [Ca2+]i. Indeed, in 3 µM free calcium, JMV5656
failed to activated a large outward current, consistent with the
prevalence of KCa3.1 already activated (hypothesis confirmed
also by the hyperpolarization of the Vrev already significant
before the peptide perfusion). Finally, the partial silencing of the
mRNA for KCa3.1 reduced the number of cells responsive to
JMV5656.
It is interesting at this point at least TO speculate what
the sources for the JMV565 triggered Ca2+ influx could be.
The data obtained in presence of BAPTA in the intracellular
solution suggested a coupling between the calcium source and
the calcium sensor (KCa) in the nanometers range (Fakler and
Adelman, 2008). In fact, in accordance with this interpretation,
BAPTA, with its 150 times faster calcium binding rate compared
to EGTA, thus more effective in preventing calcium diffusion,
interfered with the outcome of JMV5656. Extracellular calcium
was necessary to activate JMV5656 response, thus one may
think that calcium channels on the plasma membrane may
be the primum movens required to trigger the KCa activation
which may be found in their very close proximity. In
microglial cells, L-type calcium channels are indeed present
and preliminary data (not shown) from our lab indicated
that nifedipine (10 µM) blunted the increase of the outward
current JMV5656-mediated (only 40% respect to the baseline),
suggesting a potential involvement of L-type calcium channel
in the activation of the KCa. But, since the outward current
required at least 25 s of peptide perfusion to manifest,
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it would be hard to think at a direct effect of the peptide on the
L-type calcium channel opening, but quite reasonably this delay
is more consistent with the generation of second messengers that
may affect the Ca2+ channel activity.
Thus, we suggest that JMV5656 acting on its receptor(s)
generates an increase in cytosolic calcium that, together with the
depolarization, may open calcium channels (L-type?) found on
the plasma membrane of the N9 cells. The calcium ions entered
through this route might favor the activation of an outward
potassium current mediated mainly by KCa3.1 found in their
nanometers range proximity.
The ability of JMV5656 (and TLQP-21) to stimulate
microglia cells is an interesting finding that might help
for the development of antagonist as new therapeutic
tools for the care and the treatment of neuropathic pain.
In fact, it has been reported that injection of TLQP-21
into the hind paw of mice resulted in hypersensitivity in
both control conditions and in a model of inflammatory
pain (Rizzi et al., 2008). In the dorsal horn, stimulation
of microglia by TLQP-21 could lead to production and
secretion of cytokines responsible for the activation of sensory
neurons. Recently the gC1qR and C3AR1 complement protein
receptors, have been proposed to be involved in the TLQP-21
mechanism of action (Chen et al., 2013; Hannedouche et al.,
2013).
CONCLUSION
By measuring the outward K+ currents, we were able to
demonstrate that by interacting with its cellular receptors,
JMV5656, a derivative of TLQP-21, was capable to stimulate
increase in intracellular calcium, which activated, even not
in exclusively manner, KCa3.1 channels in N9 microglia
cells. The opening of KCa3.1 channels is important for the
hyperpolarization of the plasma membrane which allows
maintaining the driving force for Ca2+ to entry from the
extracellular environment and an optimal replenishment of
intracellular Ca2+ stores.
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